Status:
UNKNOWN
Diagnosis of Active Tuberculosis by ELISPOT
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Tuberculosis
Eligibility:
All Genders
Brief Summary
Recent studies revealed that the ex vivo enzyme-linked immunospot (ELISPOT) assay for gamma interferon is a specific method for contact tracing of Mycobacterium tuberculosis infection. However, its us...
Eligibility Criteria
Inclusion
- Patients who present with fever or respiratory symptoms (cough, dyspnea, or hemoptysis) lasting for ≥ 2 weeks and have compatible radiographic findings were considered clinical suspects of TB.
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00174083
Start Date
August 1 2005
End Date
December 1 2006
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan